← FDA DRUG APPROVALS

FDA ANDA · ANDA065018

CEFADROXIL

Sponsor: RANBAXY

APPLICATION
ANDA065018
TYPE
ANDA
ORIGINAL APPROVAL
1999-04-23
LATEST ACTION
2000-10-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CEFADROXILDiscontinued
CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 1GM BASE · TABLET · ORAL

Approval history

2000-10-18Manufacturing (CMC) · Supplement 2AP
2000-06-29Manufacturing (CMC) · Supplement 1AP
1999-04-23OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →